Pregled bibliografske jedinice broj: 1260348
Subtyping of triple-negative breast cancer
Subtyping of triple-negative breast cancer // Libri Oncologici : Croatian Journal of Oncology, Vol. 50 No. Supplement 1, 2022.
Opatija, Hrvatska, 2022. str. 145-145 (poster, domaća recenzija, sažetak, stručni)
CROSBI ID: 1260348 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Subtyping of triple-negative breast cancer
Autori
Ramić, Snježana ; Cesarec Augustinović, Sanja ; Puhalo, Ana ; Karačić, Ena ; Perić Balja, Melita
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Libri Oncologici : Croatian Journal of Oncology, Vol. 50 No. Supplement 1, 2022.
/ - , 2022, 145-145
Skup
15. Hrvatski onkološki kongres
Mjesto i datum
Opatija, Hrvatska, 31.03.2022. - 03.04.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
triple-negative breast cancer, subtypes, androgen receptor, CK5/14, EGFR, PD-L1
Sažetak
Recent researches show a high heterogeneity of triple-negative breast cancers (TNBC).Subtyping of TNBC would better select patients for different therapeutic approaches.That would ensure proper treatment in the early stages of cancer, which increases the effectiveness of treatment and better control of the disease.Based on the expression of AR, CK5/14, EGFR, and PDL1, we cannot fully classify TNBC.However, determining the underlying subgroup (basal-like or luminal) and the expression of markers that may have therapeutic significance (EGFR, PD-L1) stratify patients suitable for tailoredtherapeutic options.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore
Profili:
Snježana Ramić
(autor)
Sanja Cesarec Augustinović
(autor)
Melita Perić Balja
(autor)
Ena Karačić
(autor)